Sector Update: Health Care Stocks Softer Wednesday Afternoon

MT Newswires Live07-10

Health care stocks were edging lower Wednesday afternoon, with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) each easing about 0.1%.

The iShares Biotechnology ETF (IBB) climbed 1.9%.

In corporate news, UnitedHealth Group's (UNH) Medicare billing practices are under investigation by the US Justice Department's criminal healthcare-fraud unit, The Wall Street Journal reported. UnitedHealth shares fell 1.6%.

Merck (MRK) agreed to buy UK-based Verona Pharma (VRNA) in a deal worth $10 billion to expand its cardio-pulmonary disease treatment portfolio. Merck shares rose 3.2%, and Verona jumped past 20%.

CVS Health's (CVS) Omnicare unit was ordered to pay $948.8 million in penalties and damages in a whistleblower lawsuit alleging it fraudulently billed the US government for invalid drug prescriptions, Reuters reported, citing a court order. CVS shares were down 0.5%.

Rhythm Pharmaceuticals (RYTM) shares jumped 35% after the company said bivamelagon achieved body mass index reductions in patients in a phase 2 acquired hypothalamic obesity trial.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment